Which hedge funds own NRIX? NURIX THERAPEUTICS INC, Q2 2026 13F holders
42 tracked hedge funds disclosed a position in NRIX (NURIX THERAPEUTICS INC) in their Q2 2026 13F filings, worth $1.2bn in total. The largest holder by portfolio weight is Redmile Group, LLC at 6.6% of its book. 13 opened a new position this quarter: Diadema Partners LP, Sofinnova Investments, Inc., EcoR1 Capital, LLC, Persistent Asset Partners Ltd. 11 exited: Commodore Capital LP, Stempoint Capital LP, Integral Health Asset Management, LLC.
- 42
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 13
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 11
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $42.3m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $58.9m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $1.2bn
- Combined value Sum of the holders' reported positions in the security.
- 3.4%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Commodore Capital LP | 2.0% | $35.3m |
| Stempoint Capital LP | 0.9% | $4.9m |
| Integral Health Asset Management, LLC | 0.6% | $10.8m |
| AlphaGrep UK Ltd | 0.09% | $296k |
| Cinctive Capital Management LP | 0.05% | $700k |
| Fox Run Management, L.L.C. | 0.04% | $213k |
| Cygnus Capital Advisors, LLC | 0.03% | $51.0k |
| ExodusPoint Capital Management, LP | 0.01% | $969k |
| Squarepoint Ops LLC | 0.01% | $3.5m |
| Brevan Howard Capital Management LP | 0.0% | $411k |
| Renaissance Technologies LLC | 0.0% | $1.8m |
Ownership over time
Who discovered NRIX first? Beta
| Redmile Group, LLC high conviction | Q3 2024 | +2.2 pts |
| Deep Track Capital, LP | Q2 2022 | +1.5 pts |
| Affinity Asset Advisors, LLC | Q1 2024 | +1.0 pts |
| Ikarian Capital, LLC | Q2 2024 | +0.4 pts |
| Logos Global Management LP | Q3 2020 | −0.1 pts |
| EcoR1 Capital, LLC | Q3 2020 | −0.7 pts |
| Soleus Capital Management, L.P. | Q4 2021 | −1.0 pts |
| DAFNA Capital Management LLC | Q1 2021 | −2.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.